Skip to main navigation
Top bar
logo

Ayala - Corp Menu

  • Who We Are
    • Our Mission
    • Meet Our Team
  • Pipeline
    • Our Approach
    • Gamma Secretase Inhibitors (GSIs)
    • Investigational Therapies: AL101 and AL102
  • Clinical Trials
    • Clinical Privacy Notice
  • Medical Professionals
  • Patients & Caregivers
    • Science Explained
    • Participating In Clinical Trials
    • Expanded Access Policy
    • Patient Resources
  • Investors & Media
    • Investors
    • News Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Partners

Committee Composition

Ayala - Corp Governance Submenu

  • Documents & Charters
  • Management Team
  • Board of Directors
  • Committee Composition

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Murray Goldberg Audit Committee
David Sidransky, M.D. Compensation Committee Nominating and Corporate Governance Committee
Todd Sone Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Robert Spiegel, M.D., FACP Audit Committee Compensation Committee
= Chairperson = Member

Ayala - Investor Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
US Address
1007 North Orange Street, 4th Floor,
Wilmington, DE 19801
+1-857-444-0553
 
Israel Address
4 Oppenheimer Street, Rehovot
7670104 Israel
+972-8-373-1541
Investor Relations
ir@ayalapharma.com
 
Questions
info@ayalapharma.com
 
Careers
jobs@ayalapharma.com
 

Email Alerts

Required fields denoted by an asterisk ().
Alert type
© Ayala Pharmaceuticals. All rights reserved. Privacy Policy | Terms of Use
  • Facebook
  • Twitter
  • LinkedIn
  • Google+